Save the date for Retina International World Congress 2024 June 5-8 Dublin, Ireland
Author: Claire TEST
FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness
Roche announced positive new data from two global phase III studies
Winter Newsletter 2022
Economic Burden of Ageing Eye conditions estimated on the scale of up to billions in USA, Germany and Bulgaria
Age-related Macular Degeneration (AMD): An Overview
World Retina Day 2022: Highlighting the Challenges Faced by Those Living with Retinal Conditions Post-Lockdown
World Retina Day 2022 – Theme Announcement
Trinity team’s new gene therapy shows promise for treating eye condition affecting millions across the globe
ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs
2022 Retina International World Congress Highlights
Deafblind Awareness Week: Interview with Karan Nagrani
-
close